Oncoliq: Test for Early Breast Cancer Detection.

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

August 1, 2024

Study Completion Date

August 1, 2025

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

Oncoliq: test for early breast cancer detection.

Oncoliq is a novel early detection breast cancer test based on liquid biopsies and miRNAs. The main advantage of this test is that miRNAs released from the tumor into the bloodstream can be detected in the plasma of patients even when the tumor is undetectable by other methods.

Trial Locations (1)

C1426BOR

RECRUITING

Hospital Militar Central, CABA

All Listed Sponsors
collaborator

Instituto Nacional del Cáncer, Argentina

OTHER_GOV

lead

Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich

OTHER